Community lists
キュレーション · ヘルスケア

Big pharma

InspectStocks 編集Published 2026年10月14日13 companies0 followers

The largest drugmakers, selling prescription medicines worldwide.

AI モデルの助けを借りてグループ分けし、編集部が確認しました。各企業の下の一行が、ここに入っている理由を説明します。

Sign in to followSign in to copy
Download image
カードティア
A
  • LLYELI Lilly
    $1,437.79+42.2% 1Y

    Sells prescription medicines for diabetes, obesity, cancer and inflammation

  • JNJJohnson & Johnson
    $280.34+47.5% 1Y

    Sells prescription medicines for cancer and immune disorders

  • MRKMerck
    $147.20+65.7% 1Y

    Sells prescription medicines and vaccines for people and animals

  • NVSNovartis
    $160.36+23.6% 1Y

    Sells prescription medicines

  • AMGNAmgen
    $468.13+43.1% 1Y

    Develops and sells medicines and biosimilars for serious diseases

  • GSKGSK
    $50.60+8.9% 1Y

    Sells prescription medicines and vaccines worldwide

  • TAKTakeda Pharmaceutical
    $20.86+50.1% 1Y

    Sells prescription medicines and vaccines globally

B
  • ABBVAbbVie
    $294.87+30.2% 1Y

    Sells medicines for immune, neurological and cancer conditions

  • AZN成長が鈍っているため 1 段階下げAstrazeneca
    $185.49+115.2% 1Y

    Sells prescription medicines

  • SNYSanofi
    $48.43-3.0% 1Y

    Sells prescription medicines and vaccines

C
  • NVONovo Nordisk A/S
    $41.10-15.4% 1Y

    Sells diabetes and obesity medicines

  • PFE成長が鈍っているため 1 段階下げPfizer
    $29.45+21.4% 1Y

    Sells prescription medicines and vaccines

  • BMYBristol-Myers Squibb
    $62.92+34.0% 1Y

    Sells prescription medicines for cancer and immune conditions

D

この評価の企業はここにはありません。

F

この評価の企業はここにはありません。

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.